| Drug Name |
Loxapine |
| Drug ID |
BADD_D01326 |
| Description |
An antipsychotic agent used in schizophrenia. [PubChem] |
| Indications and Usage |
For the management of the manifestations of psychotic disorders such as schizophrenia |
| Marketing Status |
Prescription; Discontinued |
| ATC Code |
N05AH01 |
| DrugBank ID |
DB00408
|
| KEGG ID |
D02340
|
| MeSH ID |
D008152
|
| PubChem ID |
3964
|
| TTD Drug ID |
D0U5OE
|
| NDC Product Code |
0527-1395; 64850-891; 70518-1896; 0527-1397; 35573-438; 0591-0371; 70518-0346; 70518-2120; 0527-1396; 35573-437; 0527-1394; 64850-893; 0591-0372; 0591-0369; 70518-0416; 35573-436; 0591-0370; 64850-890; 64850-892; 70518-1681; 53296-0095; 50090-4701; 70518-0283; 35573-439; 70518-0347 |
| Synonyms |
Loxapine | 2-Chloro-11-(4-methyl-1-piperazinyl)-dibenz(b,f)(1,4)oxazepine | Oxilapine | Cloxazepine | Loxapine Hydrochloride | Hydrochloride, Loxapine | Loxitane | Loxapine Succinate | Succinate, Loxapine | Loxapinsuccinate | Loxipine Succinate | Loxipine Maleate | Maleate, Loxipine | CL-71,563 | CL 71,563 | CL71,563 | Loxapine Monohydrochloride |
